PubMed 5 Slomiany MG, Rosenzweig SA: IGF-1-induced VEGF and IGFB

PubMed 5. Slomiany MG, Rosenzweig SA: IGF-1-induced VEGF and IGFBP-3 secretion correlates with increased HIF-1 alpha expression and activity in retinal pigment epithelial cell line D407. Invest Ophthalmol Vis Sci 2004, 45:2838–2847.PubMedCrossRef 6. Smith LE, Shen W, Perruzzi C, Soker S, Kinose F, Xu X, Robinson G, Driver S, Bischoff J, Zhang B, Schaeffer JM, Senger DR: Regulation of vascular endothelial www.selleckchem.com/products/p5091-p005091.html growth factor-dependent retinal CAL101 neovascularization by insulin-like growth factor-1 receptor. Nat Med 1999, 5:1390–1395.PubMedCrossRef 7. Liu WD, Yu R, Zhou GR: [Expression and significance of IGF-1R and VEGF in gastric carcinoma.]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2009, 25:529–530.PubMed 8. Moser C, Schachtschneider P, Lang

SA, Gaumann A, Mori A, Zimmermann J, Schlitt HJ, Geissler EK, Stoeltzing O: Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis. Eur J Cancer 2008, 44:1577–1586.PubMedCrossRef 9. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR: Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the

secreted protein IGFBP7. Cell 2008, 132:363–374.PubMedCrossRef 10. Hwa V, Oh Y, Rosenfeld RG: The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 1999, 20:761–787.PubMedCrossRef 11. Collet C, Candy J: How many insulin-like growth factor binding proteins? Mol Cell Endocrinol 1998, 139:1–6.PubMedCrossRef 12. Wilson HM, Birnbaum RS, Poot M, Quinn LS, Swisshelm K: Insulin-like growth factor I-BET-762 clinical trial binding protein-related protein 1 inhibits proliferation of MCF-7 breast cancer cells via a senescence-like mechanism. Cell Growth Differ 2002, 13:205–213.PubMed 13. Sprenger CC, Damon SE, Hwa V, Rosenfeld RG, Plymate SR: Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) Niclosamide is a potential tumor suppressor

protein for prostate cancer. Cancer Res 1999, 59:2370–2375.PubMed 14. Rajaram S, Baylink DJ, Mohan S: Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 1997, 18:801–831.PubMedCrossRef 15. Sicklick JK, Li YX, Jayaraman A, Kannangai R, Qi Y, Vivekanandan P, Ludlow JW, Owzar K, Chen W, Torbenson MS, Diehl AM: Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis. Carcinogenesis 2006, 27:748–757.PubMedCrossRef 16. Bhattacharyya N, Pechhold K, Shahjee H, Zappala G, Elbi C, Raaka B, Wiench M, Hong J, Rechler MM: Nonsecreted insulin-like growth factor binding protein-3 (IGFBP-3) can induce apoptosis in human prostate cancer cells by IGF-independent mechanisms without being concentrated in the nucleus. J Biol Chem 2006, 281:24588–24601.PubMedCrossRef 17. Chen ZY, Liang K, Xie MX, Wang XF, Lu Q, Zhang J: Induced apoptosis with ultrasound-mediated microbubble destruction and shRNA targeting survivin in transplanted tumors. Adv Ther 2009, 26:99–106.PubMedCrossRef 18.

Comments are closed.